Since 1987, this dedicated community has stood shoulder to shoulder with the SRF, helping to drive research toward a cure for scleroderma. Because of your generosity and commitment, 2024 was a milestone year like no other.
Here are just a few highlights of the progress you helped us achieve in 2024:
➡️ CONQUEST, our groundbreaking platform clinical trial, is now enrolling participants at 68 sites in 13 countries, with more sites to come in the new year
➡️ $6.7M+ invested this year alone in the most promising scleroderma research
➡️ 1,115 patients enrolled in the CONQUER registry, contributing critical data that can be used to improve care and develop new therapies
➡️ 3,500+ views of educational content from our 2024 Patient Forum webinars
➡️ A new clinical trial finder on our website, so that whether you’re ready to explore participation or just want to learn more, you have resources that can help
We are committed to finding a cure because no one should have to live with scleroderma. Research is at the center of everything we do, and it’s only possible because of your partnership. Together, we are changing lives—and we won’t stop until we end this disease.
